Dinfectome Receives Chinese NMPA Approval for New NGS Sequencer
Dinfectome Inc., announced on Tuesday that its DIFSEQ-200 sequencer gained approval from the Chinese National Medical Products Administration (NMPA) on November 8, 2023
Data Field Academic | mNGS Rapid Diagnosis of Copperophilus Girardi Infected COVID-19 Rehabilitation Patient Case Report
Introduction In July 2023, Professor Han Wei’s team from Qingdao Hospital of Rehabilitation University (Qingdao Municipal Hospital) published an article in the International Journal of Infectious Diseases (IF=8.4) that Copperophilus Girardi in convalescent patients with COVID-19 A case report of an infection caused by a medium, to explore the clinical value of mNGS technology in the rapid diagnosis of rare pathogen infection.
Dickinson Academy | mNGS confirms that Corynebacterium striatae causes infective endocarditis after kidney transplantation
In August 2022, the team of Professor Tian Ye from the Urology Department of Beijing Friendship Hospital Affiliated to Capital Medical University, in cooperation with Difei Medical, published a case report in the journal Infection and Drug Resistance (IF=4.1772), describing a case of Corynebacterium striata. Diagnosis and treatment process of a 35-year-old male patient with congenital valvular endocarditis.Metagenomic sequencing of mitral valve and neoplastic tissue during treatment revealed Corynebacterium striata infection.
